Skip to contentClarengateINTELLIGENCE
Companies/12602104

Phase Biolabs Ltd

Research and experimental development on biotechnology · Nottingham

ActiveUnited KingdomIncorporated 2020Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · Company accounts

Net assets
−£1,134,825
Cash
£10,531
Turnover
—
Profit / loss
—
Current assets
£723,686
Creditors < 1 year
£1,979,078
Equity
£1,134,825
Average employees
11

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods
Reported figures2025-12-31Company2024-12-31Company2023-12-31Company2021-12-312021-05-31
Balance sheet
Net assets−£1,134,825−£19,956−£96,887£18,589£4,854
Equity£1,134,825£19,956£96,887£18,589£4,854
Assets
Fixed assets£120,567£259,829£136,284——
Property, plant & equipment£120,567£259,829£136,284——
Current assets£723,686£1,324,181£2,283,237£3,301£10,607
Cash at bank£10,531£7,254£45,469——
Debtors£713,155£1,316,927£2,237,768——
Liabilities
Creditors within one year£1,979,078£1,500,576—£21,890£15,461
Creditors after one year£0£103,390———
Net current assets−£1,255,392−£176,395£1,186,833−£18,589−£4,854
Assets less current liabilities−£1,134,825£83,434£1,323,117£18,589£4,854
People & pay
Average employees11121111
Source evidenceView filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.